View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Enfortumab Vedotin 1.25 / Pembrolizumab 200, Bladder Cancer, perioperative, cycle 4-9
Protocol-ID: 3147 V1.0 (Mini), ENFVED1,25/PEMB200, Bladder Cancer, perioperative, C4-9Indication(s)
- Bladder Cancer; ICD-10 C67.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. |
Valid since: 28.02.2026